These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11694842)

  • 1. No effect of isoniazid prophylaxis for purified protein derivative-negative HIV-infected adults living in a country with endemic tuberculosis: results of a randomized trial.
    Fitzgerald DW; Severe P; Joseph P; Mellon LR; Noel E; Johnson WD; Pape JW
    J Acquir Immune Defic Syndr; 2001 Nov; 28(3):305-7. PubMed ID: 11694842
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial.
    Fitzgerald DW; Desvarieux M; Severe P; Joseph P; Johnson WD; Pape JW
    Lancet; 2000 Oct; 356(9240):1470-4. PubMed ID: 11081529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
    Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
    Gordin F; Chaisson RE; Matts JP; Miller C; de Lourdes Garcia M; Hafner R; Valdespino JL; Coberly J; Schechter M; Klukowicz AJ; Barry MA; O'Brien RJ
    JAMA; 2000 Mar; 283(11):1445-50. PubMed ID: 10732934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of isoniazid preventive therapy for HIV-infected adults: overstatement of district reports.
    Martinson NA; McLeod KE; Milovanovic M; Msandiwa R; Lebina L
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):1005. PubMed ID: 25199022
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing latent tuberculosis among HIV-infected patients: efficacious and effective, yet inefficient?
    Rieder HL
    Clin Infect Dis; 2007 Jan; 44(1):103-4. PubMed ID: 17143824
    [No Abstract]   [Full Text] [Related]  

  • 7. Isoniazid TB prophylaxis effective in drug users with HIV.
    J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.
    Fitzgerald DW; Morse MM; Pape JW; Johnson WD
    Clin Infect Dis; 2000 Dec; 31(6):1495-7. PubMed ID: 11096020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid prophylaxis against tuberculosis in children.
    Zar HJ; Lombard C
    N Engl J Med; 2011 Oct; 365(16):1543; author reply 1543-4. PubMed ID: 22010924
    [No Abstract]   [Full Text] [Related]  

  • 10. Isoniazid preventive therapy for HIV-infected people: evidence to support implementation.
    Eldred LJ; Churchyard G; Durovni B; Godfrey-Faussett P; Grant AD; Getahun H; Chaisson RE
    AIDS; 2010 Nov; 24 Suppl 5():S1-3. PubMed ID: 21079422
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventive therapy against tuberculosis in people living with HIV.
    Wkly Epidemiol Rec; 1999 Nov; 74(46):385-98. PubMed ID: 10611855
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-term tuberculosis prophylaxis is effective in persons with HIV.
    Gordin F
    Am Fam Physician; 1998 Sep; 58(4):948. PubMed ID: 9767729
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials.
    Wilkinson D; Squire SB; Garner P
    BMJ; 1998 Sep; 317(7159):625-9. PubMed ID: 9727988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.
    Johnson JL; Okwera A; Hom DL; Mayanja H; Mutuluuza Kityo C; Nsubuga P; Nakibali JG; Loughlin AM; Yun H; Mugyenyi PN; Vernon A; Mugerwa RD; Ellner JJ; Whalen CC;
    AIDS; 2001 Nov; 15(16):2137-47. PubMed ID: 11684933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of isoniazid prophylaxis on incidence of active tuberculosis among Thai HIV-infected individuals.
    Saenghirunvattana S
    J Med Assoc Thai; 1996 May; 79(5):285-7. PubMed ID: 8708519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
    Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.
    Desvarieux M
    N Engl J Med; 1998 Mar; 338(12):841; author reply 842-3. PubMed ID: 9508639
    [No Abstract]   [Full Text] [Related]  

  • 18. Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.
    Hawken MP; Meme HK; Elliott LC; Chakaya JM; Morris JS; Githui WA; Juma ES; Odhiambo JA; Thiong'o LN; Kimari JN; Ngugi EN; Bwayo JJ; Gilks CF; Plummer FA; Porter JD; Nunn PP; McAdam KP
    AIDS; 1997 Jun; 11(7):875-82. PubMed ID: 9189212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.
    Robert M; Todd J; Ngowi BJ; Msuya SE; Ramadhani A; Sambu V; Jerry I; Mujuni MR; Mahande MJ; Ngocho JS; Maokola W
    BMC Infect Dis; 2020 Apr; 20(1):276. PubMed ID: 32276618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
    Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
    Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.